Melatonin suppresses atherosclerosis by ferroptosis inhibition via activating NRF2 pathway
The FASEB Journal · 31.05.2024 · 38 (10)
DOI: 10.1096/fj.202400427rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 23.05.2024. Verfasst von Yangyang Tao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Atherosclerosis, Ferroptosis, Melatonin, NF-E2-Related Factor 2. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Key Support Program of the Regional Innovation and Development Joint Project of the National Natural Science Foundation of China, Excellent Youth Foundation of Heilongjiang Province of China, Key Research and Development Plan Projects of Heilongjiang Province.
Abstract (Originalsprache)
Melatonin (MLT), a conserved small indole compound, exhibits anti‐inflammatory and antioxidant properties, contributing to its cardioprotective effects. Lipoprotein‐associated phospholipase A2 (Lp‐PLA2) is associated with atherosclerosis disease risk, and is known as an atherosclerosis risk biomarker. This study aimed to investigate the impact of MLT on Lp‐PLA2 expression in the atherosclerotic process and explore the underlying mechanisms involved. In vivo, ApoE −/− mice were fed a high‐fat diet, with or without MLT administration, after which the plaque area and collagen content were assessed. Macrophages were pretreated with MLT combined with ox‐LDL, and the levels of ferroptosis‐related proteins, NRF2 activation, mitochondrial function, and oxidative stress were measured. MLT administration significantly attenuated atherosclerotic plaque progression, as evidenced by decreased plaque area and increased collagen. Compared with those in the high‐fat diet (HD) group, the levels of glutathione peroxidase 4 (GPX4) and SLC7A11 (xCT, a cystine/glutamate transporter) in atherosclerotic root macrophages were significantly increased in the MLT group. In vitro, MLT activated the nuclear factor‐E2‐related Factor 2 (NRF2)/SLC7A11/GPX4 signaling pathway, enhancing antioxidant capacity while reducing lipid peroxidation and suppressing Lp‐PLA2 expression in macrophages. Moreover, MLT reversed ox‐LDL‐induced ferroptosis, through the use of ferrostatin‐1 (a ferroptosis inhibitor) and/or erastin (a ferroptosis activator). Furthermore, the protective effects of MLT on Lp‐PLA2 expression, antioxidant capacity, lipid peroxidation, and ferroptosis were decreased in ML385 (a specific NRF2 inhibitor)‐treated macrophages and in AAV‐sh‐NRF2 treated ApoE −/− mice. MLT suppresses Lp‐PLA2 expression and atherosclerosis processes by inhibiting macrophage ferroptosis and partially activating the NRF2 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Interventional Radiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Cardiology, The First Affiliated Hospital of Jiamusi University, jiamusi, China.
- Department of Medical Services, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
ORCID-Profile: Yangyang Tao, Qinglong Zhao, Chengbo Lu, Weilin Yong, Mingyuan Xu, Zhuo Wang, Xiaoping Leng
Förderung
- Key Support Program of the Regional Innovation and Development Joint Project of the National Natural Science Foundation of China
- Excellent Youth Foundation of Heilongjiang Province of China
- Key Research and Development Plan Projects of Heilongjiang Province
- National Natural Science Foundation of China
- Natural Science Foundation of Heilongjiang Province
Zitieren
APA
Tao, Y., Zhao, Q., Lu, C., Yong, W., Xu, M., Wang, Z., & Leng, X. (2024). Melatonin suppresses atherosclerosis by ferroptosis inhibition via activating NRF2 pathway. The FASEB Journal, 38(10). https://doi.org/10.1096/fj.202400427rr
Vancouver
Tao Y, Zhao Q, Lu C, Yong W, Xu M, Wang Z, et al. Melatonin suppresses atherosclerosis by ferroptosis inhibition via activating NRF2 pathway. The FASEB Journal. 2024;38(10). doi:10.1096/fj.202400427rr
BibTeX
@article{Tao2024,
author = {Tao, Yangyang and Zhao, Qinglong and Lu, Chengbo and Yong, Weilin and Xu, Mingyuan and Wang, Zhuo and Leng, Xiaoping},
title = {Melatonin suppresses atherosclerosis by ferroptosis inhibition via activating NRF2 pathway},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {10},
doi = {10.1096/fj.202400427rr}
}
EUVIMED